Fidelity International’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $526M | Buy |
12,332,054
+9,117,938
| +284% | +$495M | 0.38% | 60 |
|
|
2026
Q1 | $202M | Sell |
3,214,116
-1,543,963
| -32% | -$124M | 0.16% | 150 |
|
|
2025
Q4 | $454M | Buy |
4,758,079
+99,580
| +2% | +$9.76M | 0.34% | 74 |
|
|
2025
Q3 | $455M | Sell |
4,658,499
-220,447
| -5% | -$22.8M | 0.36% | 78 |
|
|
2025
Q2 | $524M | Sell |
4,878,946
-835,657
| -15% | -$84.6M | 0.45% | 56 |
|
|
2025
Q1 | $576M | Sell |
5,714,603
-2,180,958
| -28% | -$220M | 0.55% | 49 |
|
|
2024
Q4 | $705M | Sell |
7,895,561
-424,779
| -5% | -$37.4M | 0.66% | 35 |
|
|
2024
Q3 | $697M | Buy |
8,320,340
+922,778
| +12% | +$72.7M | 0.63% | 38 |
|
|
2024
Q2 | $570M | Buy |
7,397,562
+1,788,449
| +32% | +$131M | 0.56% | 42 |
|
|
2024
Q1 | $384M | Sell |
5,609,113
-335,633
| -6% | -$21.6M | 0.38% | 72 |
|
|
2023
Q4 | $344M | Buy |
5,944,746
+80,534
| +1% | +$4.3M | 0.36% | 74 |
|
|
2023
Q3 | $310M | Sell |
5,864,212
-1,340,109
| -19% | -$70.3M | 0.36% | 77 |
|
|
2023
Q2 | $390M | Sell |
7,204,321
-1,589,254
| -18% | -$83M | 0.44% | 60 |
|
|
2023
Q1 | $440M | Sell |
8,793,575
-22,939
| -0.3% | -$1.08M | 0.5% | 51 |
|
|
2022
Q4 | $408M | Buy |
8,816,514
+750,298
| +9% | +$32.5M | 0.49% | 50 |
|
|
2022
Q3 | $312M | Buy |
8,066,216
+133,568
| +2% | +$5.36M | 0.4% | 64 |
|
|
2022
Q2 | $296M | Buy |
7,932,648
+84,599
| +1% | +$3.44M | 0.35% | 75 |
|
|
2022
Q1 | $348M | Buy |
7,848,049
+847,580
| +12% | +$36.7M | 0.36% | 77 |
|
|
2021
Q4 | $297M | Buy |
7,000,469
+794,032
| +13% | +$33.4M | 0.31% | 82 |
|
|
2021
Q3 | $269M | Buy |
6,206,437
+2,176,240
| +54% | +$96.3M | 0.3% | 83 |
|
|
2021
Q2 | $172M | Buy |
4,030,197
+657,880
| +20% | +$27.7M | 0.19% | 141 |
|
|
2021
Q1 | $130M | Buy |
3,372,317
+295,203
| +10% | +$11.2M | 0.15% | 167 |
|
|
2020
Q4 | $111M | Buy |
3,077,114
+85,545
| +3% | +$3.08M | 0.14% | 180 |
|
|
2020
Q3 | $114M | Sell |
2,991,569
-127,095
| -4% | -$4.9M | 0.14% | 170 |
|
|
2020
Q2 | $109M | Buy |
3,118,664
+737,366
| +31% | +$26.6M | 0.15% | 164 |
|
|
2020
Q1 | $77.7M | Sell |
2,381,298
-1,929,624
| -45% | -$75.4M | 0.13% | 170 |
|
|
2019
Q4 | $195M | Buy |
4,310,922
+410,845
| +11% | +$17.2M | 0.27% | 96 |
|
|
2019
Q3 | $159M | Buy |
3,900,077
+786,656
| +25% | +$33.3M | 0.24% | 110 |
|
|
2019
Q2 | $134M | Buy |
3,113,421
+270,213
| +10% | +$10.4M | 0.2% | 134 |
|
|
2019
Q1 | $109M | Buy |
2,843,208
+341,571
| +14% | +$13M | 0.17% | 147 |
|
|
2018
Q4 | $88.4M | Sell |
2,501,637
-456,062
| -15% | -$16.5M | 0.16% | 164 |
|
|
2018
Q3 | $114M | Buy |
2,957,699
+252,421
| +9% | +$8.82M | 0.17% | 156 |
|
|
2018
Q2 | $88.5M | Buy |
2,705,278
+73,138
| +3% | +$2.21M | 0.13% | 180 |
|
|
2018
Q1 | $71.9M | Buy |
2,632,140
+201,519
| +8% | +$5.48M | 0.2% | 136 |
|
|
2017
Q4 | $60.3M | Buy |
2,430,621
+794,172
| +49% | +$21.9M | 0.17% | 143 |
|
|
2017
Q3 | $47.7M | Buy |
1,636,449
+406,257
| +33% | +$11.2M | 0.14% | 158 |
|
|
2017
Q2 | $34.1M | Buy |
+1,230,192
| New | +$32.6M | 0.1% | 185 |
|
|
2014
Q2 | – | Sell |
-285,400
| Closed | -$3.86M | – | 503 |
|
|
2014
Q1 | $3.86M | Buy |
285,400
+217,200
| +318% | +$2.85M | 0.01% | 443 |
|
|
2013
Q4 | $820K | Sell |
68,200
-8,500
| -11% | -$100K | ﹤0.01% | 481 |
|
|
2013
Q3 | $900K | Sell |
76,700
-10,000
| -12% | -$108K | ﹤0.01% | 490 |
|
|
2013
Q2 | $804K | Buy |
+86,700
| New | +$735K | ﹤0.01% | 449 |
|
Other funds holding BSX
VCM
VPM
Fidelity International's BSX Position: Q2 2026 in Review
Fidelity International increased its Boston Scientific (BSX) stake by 284% in Q2 2026, buying an estimated $495M and bringing the position to 12,332,054 shares worth $526M. The position accounts for 0.38% of the portfolio, ranked #60.
Fidelity International first reported a position in BSX in Q2 2013 and has held it in 41 quarters since. The position peaked at $705M in Q4 2024. 1,209 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Fidelity International held 12,332,054 shares of Boston Scientific worth $526M as of Q2 2026.
- Fidelity International bought 9,117,938 Boston Scientific shares in Q2 2026, an estimated $495M.
- Boston Scientific made up 0.38% of Fidelity International's portfolio in Q2 2026, its #60 holding.
- Fidelity International first reported a position in Boston Scientific in Q2 2013 and has held it in 41 quarters since.
- Fidelity International's Boston Scientific position peaked at $705M in Q4 2024.
- 1,209 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.